Medicated Skin Care in Australia

February 2012 | 34 pages | ID: M476FE02520EN
Euromonitor International Ltd

Abstracts

Value growth of 4% in medicated skin care in 2011 was largely generated by changes in Australia’s demographic mix, particularly in relation to age. Succinctly, growth was driven by the two fastest growing age groups: babies, the number of which peaked in 2010, and elderly Australians. The record number of babies in Australia in 2011 represented the major driver of the growth in nappy rash treatments, which grew by 8%, making nappy rash the fastest growing niche in medicated skin care.

Euromonitor International's Medicated Skin Care in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Medicated Confectionery, Medicated Shampoos, Motion Sickness Remedies, Nappy (Diaper) Rash Treatments, NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT, Paediatric Cough, Cold and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical Allergy Remedies/Antihistamines, Topical Analgesics/Anaesthetic, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Medicated Skin Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Ego Pharmaceuticals Pty Ltd in Consumer Health (australia)
Strategic Direction
Key Facts
  Summary 1 Ego Pharmaceuticals Pty Ltd: Key Facts
  Summary 2 Ego Pharmaceuticals Pty Ltd: Operational Indicators
Company Background
Production
  Summary 3 Ego Pharmaceuticals Pty Ltd: Production Statistics 2011
Competitive Positioning
  Summary 4 Ego Pharmaceuticals Pty Ltd: Competitive Position 2011
Herron Pharmaceuticals Pty Ltd in Consumer Health (australia)
Strategic Direction
Key Facts
  Summary 5 Herron Pharmaceuticals Pty Ltd: Key Facts
Company Background
Production
  Summary 6 Herron Pharmaceuticals Pty Ltd: Production Statistics 2011
Competitive Positioning
  Summary 7 Herron Pharmaceuticals Pty Ltd: Competitive Position 2011
Pharmacare Laboratories Pty Ltd in Consumer Health (australia)
Strategic Direction
Key Facts
  Summary 8 Pharmacare Laboratories Pty Ltd: Key Facts
  Summary 9 Pharmacare Laboratories Pty Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 10 Pharmacare Laboratories Pty Ltd: Competitive Position 2011
Executive Summary
Sick Australia Means A Healthy Industry
Australia Gets Older and Fatter
Sanofi-aventis Remains Number One
Supermarkets Expand Their Range
Consumer Health Rides Demographic Wave
Key Trends and Developments
Australian Economy Weakening
Ageing Population
Birth Rate
the Rise of the Parapharmacy
Obesity
Australia Sneezes
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements' Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 11 OTC - Switches 2009-2011
Sources
  Summary 12 Research Sources